Starpharma Holdings Limited (ASX: SPL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Starpharma Holdings Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Starpharma Holdings Limited (ASX: SPL)
Latest News
Share Gainers
Why a2 Milk, Orocobre, Select Harvests, & Starpharma shares are pushing higher
Share Gainers
Starpharma share price charges higher on positive trial results
Share Market News
Starpharma share price on watch after European approval news
Share Market News
Starpharma share price charges higher on UK VivaGel BV launch
Share Gainers
Starpharma share price on watch after latest trial results
Share Gainers
Why the Starpharma share price raced 5% higher today
Share Fallers
Why Clinuvel, Newcrest, Starpharma, & Wattle Health shares dropped lower
Share Gainers
Why BINGO, FlexiGroup, Monadelphous, & Starpharma shares stormed higher
Share Gainers
Starpharma share price surges 9% higher on FDA authorisation news
Share Gainers
Starpharma share price higher on DEP irinotecan update
⏸️ Investing
Are Avita Medical shares a buy after rocketing 500% YTD?
Share Gainers
Starpharma share price races 6% higher on clinical trials update
Frequently Asked Questions
-
No, Starpharma does not pay dividends at this time.
-
Starpharma listed on the ASX on 28 September 2000.
SPL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Starpharma Holdings Limited
Starpharma Holdings Ltd (ASX: SPL) is an Australian biotechnology company involved in the development of dendrimer products for pharmaceutical, life science, and other applications.
Dendrimers are synthetically manufactured, nanoscale molecules, particularly useful to the pharmaceutical industry for their unique properties as carriers of other molecular structures.
Starpharma describes itself as a world leader in the field. The company is developing programs for drug delivery applications, the treatment of respiratory viruses, and its VivaGel product.
VivaGel can be used for the management and prevention of bacterial vaginosis and as a coating for condoms. The company's VIRALEZE product is an antiviral nasal spray approved for use in many countries, including Europe and the UK.
